Inflazyme Pharmaceuticals eyes $5.9M gain from reorganization

VANCOUVER (CP) - Inflazyme Pharmaceuticals Ltd. expects to gain about $5.9 million from a reorganization and the sale of one of its subsidiaries. The restructuring initially provides $3.43 million to help fund Inflazyme operations....More